Dewan Abhinav, Kumar Lalit, Chufal Kundan Singh, Bhushan Manindra, Ahmad Irfan, Barik Soumitra, Umesh Preetha, Mitra Swarupa, Mehrotra Krati
Department of Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
Division of Medical Physics, Max Saket, Delhi, India.
Asian Pac J Cancer Prev. 2025 Feb 1;26(2):631-638. doi: 10.31557/APJCP.2025.26.2.631.
To analyse the dosimetric benefit achieved with Deep inspiratory breath hold (DIBH) for left sided breast irradiation and to identify the factors impacting it.
Between 1st January'2023 to 31st December' 2023, 100 consecutive patients with left sided breast cancer receiving adjuvant radiotherapy and fulfilling the inclusion/exclusion criteria were enrolled in a prospective study conducted at Rajiv Gandhi Cancer Institute and Research Centre, New Delhi. Two radiotherapy plans (DIBH/Free breathing (FB)) were generated and evaluated for each patient. Plans were evaluated using dose-volume histogram (DVH). Anatomical and treatment parameters predicting cardiac sparing were generated.
DIBH led to improvement in dosimetry for lung and cardiac structures for all group of patients. Breathhold technique showed a significant increase in the circumference of the chest, separation and heart height. An approximately 45% increase in ipsilateral lung volume was seen with DIBH. It led to a reduction in the heart volume by 17.67%. After placement of the tangential fields, a decrease in maximum heart distance (MHD) and heart volume in treatment field (HVIF) was seen in the DIBH phase.
DIBH appears to be a useful tool for limiting cardiac and pulmonary dose in all the patients with left sided breast cancer, potentially reducing long-term complications.
分析深吸气屏气(DIBH)在左侧乳腺癌放疗中所带来的剂量学益处,并确定影响该益处的因素。
在2023年1月1日至2023年12月31日期间,100例连续接受辅助放疗且符合纳入/排除标准的左侧乳腺癌患者被纳入在新德里拉吉夫·甘地癌症研究所和研究中心进行的一项前瞻性研究。为每位患者生成并评估两个放疗计划(DIBH/自由呼吸(FB))。使用剂量体积直方图(DVH)对计划进行评估。生成预测心脏保护的解剖学和治疗参数。
DIBH使所有患者组的肺部和心脏结构的剂量学得到改善。屏气技术显示胸部周长、间距和心脏高度显著增加。DIBH使同侧肺体积增加约45%。它使心脏体积减少了17.67%。在设置切线野后,在DIBH阶段可见最大心脏距离(MHD)和治疗野中心脏体积(HVIF)减小。
DIBH似乎是限制所有左侧乳腺癌患者心脏和肺部剂量的有用工具,可能减少长期并发症。